UBS Group »

Biodexa Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Biodexa Pharmaceuticals (BDRX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Biodexa Pharmaceuticals

Nov 2023Jan 2024Mar 2024May 2024Jul 2024Sep 2024020k40k60k0100k200k
Value ($)Share countHistorical BDRX position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Biodexa Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biodexa Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $72k 255k 0.28
2024-06-30 $9.0k 10k 0.90
2024-03-31 $4.0k 2.4k 1.62
2023-12-31 $1.6k 600 2.68
2023-09-30 $353 71 4.99